Monocyte Heterogeneity and Innate Immunity  by Taylor, Philip R & Gordon, Siamon
Immunity
2
gions identified by these approaches has confirmed that a consistent set of functions can be assigned to control
regions that function as LCRs in transgenic mice. Thisthey are critical for regulation of Il4 and, in one case, Il5
and Il13 (Mohrs et al., 2001; Solymar et al., 2002). has emerged as an important question because of cur-
rent controversies surrounding the endogenous func-Although the control regions that have been charac-
terized are important for regulation of the Th2 cytokine tions of the classical -globin LCR. The properties of
the human -globin LCR in transgenic mice led to thegenes, a recent study by Lee et al. (2001) provided evi-
dence that additional control regions remained to be hypothesis that LCRs may be responsible for the initial
locus-wide changes in chromatin structure that are re-identified. When most of the well-characterized control
regions were linked to an Il4 promoter-reporter cassette quired for transcriptional activation (Grosveld, 1999).
However, subsequent deletion of the murine -globinin the context of a mouse transgene, efficient Th2-spe-
cific transcription was observed. However, transcrip- LCR from the endogenous -globin locus revealed little
effect on chromatin structure and histone tail modifica-tional activity varied greatly among the founders and
was not proportional to transgene copy number, indicat- tions. The relevant functions of the endogenous-globin
LCR remain controversial, although a recent study sug-ing the absence of an LCR.
In the current study, Lee et al. (2003) set out to deter- gests that its most pronounced function is to enhance
the transition from transcription initiation to transcrip-mine whether a large bacterial artificial chromosome
(BAC) transgene containing the Th2 cytokine cluster tion elongation by RNA polymerase II (Grosveld, 1999;
Sawado et al., 2003). It will be interesting to determinewould reveal LCR activity. Indeed, integration site-inde-
pendent, copy number-dependent transcription of Il13 whether the LCR within the Th2 cytokine cluster exhibits
a similar function, or whether LCRs support a greaterand Il4 was observed with a BAC that spans the three
Th2 cytokine genes (Il5, Il13, and Il4) and the constitu- variety of functions in their native settings.
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importance of selective monocyte recruitment in theMonocyte Heterogeneity
innate immune response to Listeria.and Innate Immunity
In its simplest interpretation, macrophages (MØ) in the
adult originate primarily in the bone marrow from a com-
mon progenitor cell shared with neutrophils. At somePeripheral monocyte heterogeneity is widely acknowl-
edged in humans but until now comparable heteroge- point the progenitor cells can become committed to the
monocytic lineage and divide to produce monocytesneity has not been characterized in mice. In this issue,
Geissmann et al. use chemokine receptors to define (Mo). Newly produced Mo are released into the blood
where they circulate for 1–3 days before entering tissuestwo monocyte subsets and Serbina et al. highlight the
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Figure 1. Schematic Representation of the Development of Two Murine Mo Subsets
During Mo differentiation and development an uncharacterized divergence occurs generating two phenotypically and functionally distinct
subsets (Q1). One Mo subset, characterized by its Gr-1CX3CR1lowCCR2CD62L phenotype, is preferentially recruited to inflammatory lesions.
The second Gr-1CX3CR1highCCR2CD62L Mo subpopulation is hypothesized to be a source of tissue resident MØ and DC (Q2). This figure
is based on Geissmann et al., 2003. *Taken from Serbina et al., 2003. **Based on Merad et al., 2002.
to differentiate into mature resident MØ (Volkman and gestive of differentiation into DC, and subsequently mi-
grated to the draining lymph nodes. The cells were ableGowans, 1965). Under inflammatory conditions, Mo pro-
duction in the bone marrow is increased and after re- to reconstitute priming of CD8 T cells in MHCI-deficient
mice, further supporting the idea that they could differ-lease into the circulation Mo are rapidly recruited to sites
of injury and infection where they differentiate into in- entiate into functional DC after recruitment to inflamed
tissue. Thus, these CCR2 Mo, which are short-livedflammatory MØ (Van Furth et al., 1973).
In 1989, Passlick et al. demonstrated that human Mo circulating cells able to differentiate into both MØ and
DC, can be tentatively classified as “inflammatory Mo”could be divided into two populations by the presence
or absence of the Fc receptor CD16 (Passlick et al., (see Figure 1).
The second subset of mouse Mo (Gr-1CX3CR1high1989). Although phenotypic and functional distinctions
between these subsets have been difficult to define, the CCR2CD62L) was found to resemble the CCR2CD16
subset of human Mo. After adoptive transfer, this sub-CD16 Mo do not express the chemokine receptor CCR2
(Weber et al., 2000) and have an enhanced capacity for population could be found in the blood, spleen, lung,
liver, and brain of recipients for several days. The distri-transendothelial migration (Randolph et al., 2002). Both
human Mo subsets are able to differentiate into dendritic bution of transferred Mo was not greatly altered in mice
with peritonitis. After transfer into naive mice, a propor-cells (DC) in culture (Sallusto and Lanzavecchia, 1994).
Since the initial description of a CD16 subset of hu- tion of the CCR2 Mo that were recovered from the
spleen had acquired CD11c and MHCII expression. Bothman Mo, and in spite of the substantial use of genetically
modified mice to model human disease, little advance these CCR2 and the CCR2 Mo, like their proposed
human counterparts, could be differentiated into DChas been made in the identification of Mo subsets in
mice. In this issue Geissmann et al. report the identifica- after in vitro culture. Thus, the CCR2 “resident Mo”
population is hypothesized to represent the precursorstion of two murine Mo subsets with distinct chemokine
receptor and adhesion molecule profiles (Geissmann et of tissue resident MØ and DC (see Figure 1), although
this has not been examined directly.al., 2003).
The first Mo subpopulation, which is characterized by As reported in this same issue, Serbina et al. have
studied the course of Listeria monocytogenes infectiona Gr-1CX3CR1lowCCR2CD62L phenotype, corre-
sponds to the CCR2CD16 human Mo. One day after in CCR2-deficient mice (Serbina et al., 2003). During
the first 48 hr of infection, bacterial burdens in CCR2-adoptive transfer into naive mice, these CCR2 cells
were almost undetectable in all tissues analyzed except deficient mice and controls were similar; however, a
significant defect was noted in the recruitment of Mac-the spleen. However, if cells were transferred into ani-
mals with experimentally induced peritonitis, they infil- 3highCD11bintCD11cint Mo/MØ-like cells into the spleen.
During the early stages of infection of wild-type mice,trated the peritoneal cavity. Furthermore, after arrival in
the inflamed peritoneal cavity, a substantial proportion these cells showed progressive increases in B7-1, B7-2,
CD40, and MHCII antigen expression and were foundof the cells acquired CD11c and MHCII expression, sug-
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to be the major source of splenic TNF at this time. Mo may have the capacity to replace Langerhans cells
during inflammation, although this would need to beThe same TNF-producing cells also expressed iNOS.
Consistent with the defect in the recruitment of these shown. The derivation of osteoclasts, which are believed
to be derived from circulating precursors, is also unclearcells, the infected CCR2-deficient animals lacked TNF
production and, like TNF-deficient mice, failed to show and requires further study.
These studies represent important first steps in thesignificant iNOS expression or NO production by spleno-
cytes. By 3–4 days after infection, the bacterial load in fine characterization of the murine Mo-MØ/DC lineages,
which are likely to facilitate the understanding of theCCR2-deficient mice exceeded that seen in wild-type
animals and was similar to that seen in iNOS-deficient role of Mo in human disease. The availability of experi-
mental and genetically altered mouse models will helpmice. CD4 and CD8 T cell responses in CCR2-defi-
cient mice were apparently normal, indicating that the us learn more about the nature of the differences be-
tween different Mo subpopulations and aid in the devel-defect in recruitment of CCR2 cells to the spleens of
infected animals resulted in deficiency of TNF/iNOS- opment of intervention strategies to target arms of the
Mo developmental pathways specifically. These princi-producing cells and a failure of the innate immune re-
sponse to control the primary infection. ples can then be taken into account in many different
inflammatory contexts such as atherosclerosis, whereIt seems likely from these two studies, although not
formally demonstrated, that the TNF/iNOS-producing the CCR2-dependent recruitment of Mo contributes sig-
nificantly to pathology (Boring et al., 1998). For example,cells recruited via CCR2 to the spleens of Listeria-
infected mice are derived from the CCR2 inflammatory blockade, depletion, or activation of inflammatory Mo in
the circulation could modulate an ongoing inflammatoryMo described by Geissmann et al.
The ability to identify and follow the activity of subsets reaction with limited impact on the constitutive replen-
ishment of tissue resident MØ and DC, which are impor-of Mo in mice and the fact that mouse Mo subsets appear
to be phenotypically similar to human Mo is a significant tant for the maintenance of homeostasis.
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